Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Kleiter

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Der Nervenarzt|March 30, 2021
[Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]Ilya Ayzenberg, Ingo Kleiter
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 25, 2015
Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersIngo Kleiter, Ralf Gold
Neurology|February 1, 2012
Immune reconstitution inflammatory syndrome in natalizumab-associated PMLKerstin Hellwig, Ingo Kleiter, Ralf Gold
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Therapeutics and Clinical Risk Management|October 15, 2013
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?Joachim Havla, Ingo Kleiter, Tania Kümpfel
Deutsches Arzteblatt International|July 25, 2009
Correspondence (letter to the editor): Effects on the Nervous SystemIngo Kleiter, Wilhelm Schulte-Mattler, Berthold Schalke
FEBS Open Bio|August 6, 2019
Tamoxifen affects chronic pancreatitis-related fibrogenesis in an experimental mouse model: an effect beyond Cre recombinationXuan Li, Christian Clappier, Ingo Kleiter, et al.
Muscle & Nerve|July 22, 2014
Allergic granulomatous skin reaction to electromyography needleIngo Kleiter, Heinrich Dickel, Silas Paras Soemantri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
JAMA Neurology|August 18, 2016
Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor EncephalitisVolker Behrendt, Christos Krogias, Anke Reinacher-Schick, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Der Nervenarzt|March 30, 2021
[Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]Ilya Ayzenberg, Ingo Kleiter
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 25, 2015
Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersIngo Kleiter, Ralf Gold
Neurology|February 1, 2012
Immune reconstitution inflammatory syndrome in natalizumab-associated PMLKerstin Hellwig, Ingo Kleiter, Ralf Gold
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Therapeutics and Clinical Risk Management|October 15, 2013
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?Joachim Havla, Ingo Kleiter, Tania Kümpfel
Deutsches Arzteblatt International|July 25, 2009
Correspondence (letter to the editor): Effects on the Nervous SystemIngo Kleiter, Wilhelm Schulte-Mattler, Berthold Schalke
FEBS Open Bio|August 6, 2019
Tamoxifen affects chronic pancreatitis-related fibrogenesis in an experimental mouse model: an effect beyond Cre recombinationXuan Li, Christian Clappier, Ingo Kleiter, et al.
Muscle & Nerve|July 22, 2014
Allergic granulomatous skin reaction to electromyography needleIngo Kleiter, Heinrich Dickel, Silas Paras Soemantri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
JAMA Neurology|August 18, 2016
Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor EncephalitisVolker Behrendt, Christos Krogias, Anke Reinacher-Schick, et al.
Pageof 15